Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for CBGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
August 31, 2025 -4.772M
May 31, 2025 -4.675M
February 28, 2025 -4.675M
November 30, 2024 -4.691M
August 31, 2024 -4.776M
May 31, 2024 -4.71M
February 29, 2024 -4.664M
November 30, 2023 -4.599M
August 31, 2023 -4.453M
May 31, 2023 -4.406M
February 28, 2023 -4.411M
November 30, 2022 -4.370M
August 31, 2022 -4.134M
May 31, 2022 3.213M
February 28, 2022 3.492M
November 30, 2021 0.5883M
August 31, 2021 2.282M
May 31, 2021 -0.3658M
February 28, 2021 0.4099M
November 30, 2020 -0.9255M
August 31, 2020
May 31, 2020 -2.015M
February 29, 2020 -0.6026M
November 30, 2019 -0.0475M
August 31, 2019 0.0614M
Date Value
May 31, 2019 -0.158M
February 28, 2019 -0.1596M
November 30, 2018 -0.1522M
August 31, 2018 -0.135M
May 31, 2018 -0.1286M
February 28, 2018 -0.122M
November 30, 2017 -0.115M
August 31, 2017 -0.0891M
May 31, 2017 -0.0869M
February 28, 2017 -0.0847M
November 30, 2016 -0.0826M
August 31, 2016 -0.0806M
May 31, 2016 -0.0785M
February 29, 2016 -0.0763M
November 30, 2015 -0.0744M
August 31, 2015 -0.0728M
May 31, 2015 -0.0642M
February 28, 2015 -0.0542M
November 30, 2014 -0.0419M
August 31, 2014 -0.0247M
May 31, 2014 -0.0155M
February 28, 2014 -0.0063M
November 30, 2013 0.0052M
August 31, 2013 0.0206M
May 31, 2013 0.0283M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. 63.61M
CorMedix, Inc. 460.83M
Eloxx Pharmaceuticals, Inc. 46.42M
Breakthrough Chemistry, Inc. 0.8373M
BioStem Technologies, Inc. 27.61M

Shareholders Equity (Quarterly) Related Metrics